Table 3.
HR (95%CI) | |||
---|---|---|---|
Model 1 | Model 2 | Model 2+medication and family history of CVD | |
None | Ref | Ref | Ref |
Mide | 2.30 (1.42, 3.73) | 2.26 (1.38, 3.69) | 2.25 (1.35, 3.71) |
Moderate-severe | 1.65 (0.82, 3.33) | 1.47 (0.72, 2.99) | 1.52 (0.73, 3.14) |
P for trend | 0.01 | 0.03 | 0.03 |
PHQ9 continuous | 1.06 (1.01, 1.11) | 1.05 (1.01, 1.10) | 1.05 (1.01, 1.10) |
Ref | Ref | Ref | |
Ever depression (N = 1,571) | 2.43 (1.37, 4.31) | 2.23 (1.25, 3.98) | 2.11 (1.16, 3.75) |
Persistent depression (N = 479) | 2.54 (1.25, 5.18) | 2.13 (1.05, 4.44) | 2.19 (1.11, 4.51) |
Model 1: age, race, sex, glucose control strategy, CVD history, living along, education status, cigarette and alcohol consumption.
Model 2: age, race, sex, glucose control strategy, CVD history, living along, education status, cigarette and alcohol consumption, BMI, Total cholesterol, triglyceride, LDL, HDL, SBP, DBP, HR, GFR.
Medication including ARB, ACEI, β-blocker, Sulphonylurea, Metformin, Meglitinide, Thiazolidinedione, Insulin, Statin, Aspirin, Anti-depression drug.
CVD, cardiovascular disease; LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; GFR, Glomerular filtration rate.